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Acute cholecystitis is a frequent cause of general surgical admissions with a mortality risk that is related
to the age of the patient. Percutaneous cholecystostomy (PC) has been used as a bridging technique while
awaiting resolution of sepsis. We evaluated the outcome of our study population following percutaneous
cholecystostomy for acute cholecystitis due to benign etiologies.
Methods: Retrospective review of patients undergoing PC from January 1988 to December 2008. Patients
were reviewed for demographic features, co-morbidity, resolution of symptoms, hospital stay, outcome,
complications and ASA class.
Results: 62 patients underwent PC for acute cholecystitis. 49 patients had calculous cholecystitis. 61%
(n ¼ 38) were 60 years old. 92% had resolution of symptoms within 48 h, and 8% had partial or no
resolution. 84% had a decline in total leucocyte counts. The mean hospital stay was 10.6 days and 30-day
mortality was 15%. 69% patients had no post-procedure complication. Of the remainder, 1 patient had
post-procedure hemorrhage and the remaining developed complications that included pneumonia,
hypotension and vasovagal reactions. The duration of drainage ranged from 1 to 3 months. 3 patients
underwent emergency cholecystectomy during the same admission, 20 patients underwent interval
cholecystectomy. 22 patients had no further intervention and had no recurrent symptoms, of these 73%
(n ¼ 16) had calculous cholecystitis. In this sub-group of non-operated patients, 76% were ASA III & IV.
Conclusions: PC is a low risk management option for high risk patients with acute cholecystitis. It can be
used as a temporizing measure while awaiting resolution of sepsis and optimization of co-morbidities, or
as a deﬁnitive therapeutic option for acalculous cholecystitis. We also conclude that it has a good
potential to be used as a deﬁnitive therapy for high risk (ASAIII & IV) patients with acute calculous
cholecystitis.
 2011 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.1. Introduction
Acute cholecystitis (AC) is one of the most frequent causes for
acute general surgical admission, with 50e70% of cases occurring in
elderly patients.1 The mortality of AC increases exponentially with
age, from 2.8% in the general population to 11.4% in those over 80
years of age. The mainstay of therapy for acute cholecystitis is
cholecystectomy, yet reported mortality rates are as high as 5%,
increasing to 14 e 30% in high risk patients such as the elderly or
critically ill. Failure of conservative management can result in
complications including perforation or gangrenous cholecystitis
requiring emergency surgical intervention with reported mortality
rates as high as 30%.2Elsevier Ltd on behalf of Surgical AThe appropriate management of acute cholecystitis in critically
ill or elderly patients with underlying medical conditions is
a controversial issue due to the high postoperative morbidity and
mortality rates after emergency cholecystectomy. Surgical chol-
ecystostomy, introduced by Bobbs, was the only available treatment
of AC for more than a century. Percutaneous cholecystostomy (PC)
was ﬁrst described in 1921 as a diagnostic test. US-guided chol-
ecystostomy for therapeutic purposes was ﬁrst reported in
1979.The ﬁrst report of PC for the management of acute cholangitis
was in 1980.2 It has been used as a relatively safe and efﬁcient
temporizing measure in the treatment of acute cholecystitis in high
risk patients with serious co-morbidity and in elderly patients,
circumventing the general anesthesia required for laparoscopic or
open cholecystectomy.3 Reported clinical response rates are in the
range of 56e100%.3e6
Drainage is followed by interval cholecystectomy after a variable
period of time. In patients with acalculous cholecystitis, percuta-
neous gall bladder drainage may be the only treatment necessary.ssociates Ltd.
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Fig. 1. Change in TLC count.
Fig. 2. Cultured organisms.
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tive procedure in the treatment of acute cholecystitis in high-risk
patients with serious co-morbidity. The aim of this study was to
determine the safety and efﬁcacy of the use of tube chol-
ecystostomy with interval laparoscopic cholecystectomy in
selected patients with acute cholecystitis and to evaluate the clin-
ical efﬁcacy and outcomes of percutaneous cholecystostomy alone
as an alternative treatment option for elderly and critically ill
patients who have acute cholecystitis.
2. Patients and method
A retrospective chart review of patients undergoing Percuta-
neous Cholecystostomy for acute cholecystitis between January
1988 and December 2008 at a tertiary care hospital was conducted.
The patients were managed by a group of six general surgeons.
Indications for the procedure included patients with ASA
grade III/IV or signiﬁcant sepsis resulting in hemodynamic
instability at the time of presentation. These patients were
deemed to be moderate or high risk for general anesthesia.
Depending on the severity of sepsis and supportive care required,
the procedure was performed either at the bedside or in the
ultrasound suite. All procedures were performed under ultra-
sound guidance. The distended gall bladder was visualized and
local anesthetic inﬁltrated into the overlying skin and subcuta-
neous tissue. The gall bladder was then cannulated with a plastic
pig-tail catheter using the Seldinger technique. The catheter was
then anchored to the skin. The possible route of the catheter was
transperitoneal or transhepatic. Initial aspirated bile was cultured
and antibiotic sensitivity of organisms isolated was established.
Subsequently, the catheter was allowed to drain by gravity.
Removal of the catheter required no anesthesia and was accom-
plished by cutting the anchoring stitch and releasing the pig-tail
string where applicable before applying gentle traction till the
catheter was retrieved.
Patients were reviewed for demographic features, co-morbidity,
resolution of symptoms, hospital stay, outcome, complications and
ASA class. All variables were recorded. SPSS (VERSION 16) was used
to analyze the data.
3. Results
Sixty-two patients had cholecystostomy tubes placed between
January 1988 and February 2009. Forty ﬁve percent (n ¼ 28) of
these patients were males and 55% (34%)were female. Sixty one
percent (n ¼ 38) of the patients were 60 years or older (mean age
63.1 years).All patients had acute cholecystitis. Of these 79%
(n ¼ 49) had calculous cholecystitis, while the remaining 21%
(n¼ 13) had acalculous cholecystitis. Seventy six percent (44) of the
patient group were ASA III/IV. The remaining 18 patients were ASA
I/II with sepsis and hemodynamic compromise.
In 27 (44%) of the patients, the route of percutaneous chole-
cystectomy was not speciﬁed in the available medical record. The
transperitoneal route was used in 22 (35%) and the transhepatic
route in 13 (21%) patients.
Ninety-two percent (n ¼ 57) had complete resolution of
symptoms within 48 h of intervention while 5% (n ¼ 3) and 3%
(n¼ 2) had partial or no resolution respectively. Eighty four percent
(n ¼ 52) patients were noted to have a decline in their total
leukocyte count (Fig.1). Bile aspirated at the time of tube placement
was culture positive in 41(66%) patients and negative in 12(19%).
Escherichia coli was the most frequently cultured pathogen (43%),
followed by Enterococcus species (11%) (Fig. 2).
The mean hospital stay for the cholecystostomy procedure was
10.6 days (10.0 days). Nine (15%) patients died within 30 days oftheir hospital stay. All deaths were attributed to persistent sepsis
and co-morbidities. One patient had post-procedural bleeding that
was managed expectantly. Sixteen patients developed complica-
tions unrelated to the procedure, including pneumonia, vasovagal
reactions, hypotension etc. Therewas no bile leak. No complication/
s was observed in 43 patients (69.4%).
A highly variable duration of drainage was observed with the
highest number of patients having the tube placed for 1e3 months
(Fig. 3). The majority of patients (43/69%) did not have a contrast
study after tube placement or before its removal. The mean follow-
up period was 403 days with a wide range of 4 dayse6 years. On
follow-up, three (4.83%) patients underwent emergency cholecys-
tectomy. Twenty (32.25%) patients subsequently underwent
interval laparoscopic cholecystectomy. Six patients (9.67%) did not
undergo a deﬁnitive treatment and complained of recurrent
symptoms and were managed conservatively.
Interestingly, 22/62 (35.48%) patients did not undergo any
further intervention following percutaneous cholecystostomy, nor
did they develop recurrent symptoms. Of these patients, sixteen
(73%) had calculous cholecystitis, while 6 (27%) had acalculous
cholecystitis. The ASA status was assessed for this non-operative
sub-group of patients (n ¼ 22). Forty seven percent were classi-
ﬁed as ASA III patients while 29% fell into the ASA IV category.
4. Discussion
Acute cholecystitis is a common disease with an incidence of
1e3% per year in patients with gallstones(10e20%). Acalculous
Fig. 3. Duration of Drainage.
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occurring most frequently after surgery or during treatment of
a critical illness in the ICU setting.7 Both variants carry a risk of
complications including empyema, gangrene, perforation, and
peritonitis. Cholecystectomy is the treatment of choice, either open
or laparoscopic. 11e20% of patients requiring cholecystectomy
present with acute cholecystitis. The application of laparoscopic
surgery has been extended to patients with acute cholecystitis,
with similar operation time, shorter hospital stay, and complication
rates when compared with open cholecystectomy. Nevertheless,
two persistent issues remain e a high rate of conversion and the
management of critically ill patients who are not good candidates
for general anesthesia. The conversion rate of laparoscopic chole-
cystectomy for acute cholecystitis has been reported to range from
11 to 28%.8
The morbidity and mortality associated with emergent chole-
cystectomy is considerably high in critically ill patients, 55%e66%
and 14%e30% respectively. In a meta-analysis, seven studies with
a total of 1408 patients undergoing laparoscopic cholecystectomy
were identiﬁed. The risks of conversion (RR 3.2, 95% CI 2.5 to 4.2)
and the overall postoperative complications (RR 1.6, 95% CI 1.2e2.2)
were signiﬁcantly higher in patients with severe acute cholecystitis.
Tube cholecystostomy with delayed laparoscopic cholecystectomy
has been proposed for the management of these patients as an
alternative treatment.9
Howard et al reported percutaneous cholecystostomy related
morbidity and a mortality of 10e12% and 0e2% respectively, which
is lesser than emergent cholecystectomy.
However, mortality rates within 30 days of percutaneous
cholecystostomy for acute cholecystitis reported in the literature
range from 18% to 69%, attributed to the presence of co-morbid
conditions in these selected patients. We report a 30 day
mortality rate of 15% following cholecystostomy. The complica-
tion rate reported by Borzellino et al for this procedure is 3e12%,
which includes hypotension, bleeding, bile peritonitis, pneumo-
thorax, empyema, pleural effusion, catheter dislodgement.
Although rare, a potentially serious complication is a bile leak
into the peritoneum, resulting in bile peritonitis and, occasionally,
sepsis. D’Agostino et al.10 found that tracts matured by 20 days in
all cases in their series. Thus, over this time, catheter removal is
expected to become safer with respect to potential bile leaks. The
morbidity related to the cholecystostomy tube was 31% in our
study and included bleeding, sepsis, pneumonia, peritonitis. We
did not encounter any bile leaks after insertion or following
removal.A low feasibility of laparoscopic cholecystectomy has been
found for severe cholecystitis. Casillas et al in their review dis-
cussed indications for PC. These included relative contraindication
to general anesthesia in 1 patient, persistent symptoms lasting
beyond 4 days in 5 patients, and a combination of resource
constraints and surgeon discretion in 13 patients. Of the 19 patients
who underwent PC, 9 eventually underwent interval LC and 10
received no further therapy. There was no statistically signiﬁcant
difference in the LOS or duration of symptoms between the groups,
however, patients in the PC (no surgery) group were 2 decades
older (P ¼ .003).11
Seventy six percent of the patients in our study were either ASA
status III or IV and 61% were older than 60 years. Clinical resolution
of toxemia was observed within 24e48 h in 92% of our patients
after cholecystostomy. This is comparable to other studies report-
ing an 81%e93% response rate. Griniatsos et al12 reported that
cholecystostomy was considered successful in 34/35 patients, 26 of
whom responded within 3 days. 17 patients were classiﬁed as ASA
score III and 7 as ASA score IV. Clinical improvement was noticed in
14 patients within 24 h and in all patients within 72 h. Statistically
signiﬁcant reduction in the values of white blood cells, C-reactive
protein, and axillary body temperature were observed within 72 h.
The procedure-related mortality was 4%, whereas within a median
follow-up of 17.5 months, deﬁnitive and effective control of
symptoms was achieved in 90.5% of the patients.
In a study conducted by Li et al,13 A total of 25 patients (10 male,
15 female) with a median age of 81 years (range, 39e97 years)
presented with acute cholecystitis and underwent percutaneous
cholecystostomy.92% of the patients clinically improved after
drainage. There was no major periprocedural complication, and
four patients had their catheter accidentally dislodged but did not
require re-insertion. Therewere ﬁve inpatient mortalities, although
the majority of these deaths were from unrelated illness. Subse-
quently, only six patients underwent elective cholecystectomy.
The small number of patients in our study prevents us from
making comparisons between different techniques of chol-
ecystostomy. However, the transperitoneal route was undertaken
in 62% of our patients who received percutaneous cholecystostomy.
The transhepatic route was used in 38% while in 44% of the cases
route of intervention was not reported. Griniatsos et al report that
the transhepatic approachminimizes the risk of intraperitoneal bile
leak and inadvertent injury to the hepatic ﬂexure of the colon, but it
carries the inherent risks of pneumothorax, intrahepatic bleeding,
and hemobiliary ﬁstula.
The management of patients after acute cholecystitis is still
controversial. Lebigot et al14 followed 16 patients for 12 months
after PC and reported only one endoscopic sphincterotomy due to
ascending cholangitis, and one delayed cholecystectomy due to
recurrence of symptoms shortly after removal of the catheter. No
additional therapy was required in the remaining patients. In
a recent study by Spira et al,15 the authors were able to apply
delayed surgery in 56.4% (n ¼ 31) of patients after the acute period.
In this study, we re-evaluated the patients after a period of stabi-
lization and optimization of concomitant medical conditions.
Twenty (32.25%) patients underwent delayed elective surgery and
the remainder were followed. The follow-up period ranges from 4
days to 6 years. Twenty-two (35.5%) patients required no additional
therapy and remained symptom free. Recurrent cholecystitis was
detected in 6(9.7%) patients and the symptoms regressed with
medical therapy.
Though the total number of patients in our study is small, it was
observed that a signiﬁcant number i.e. 22 out of 62 (35%) critically
ill patients following percutaneous cholecystostomy, did not
undergo any further treatment for cholecystitis, and eventually
remained symptom free. The reasons for not undergoing
S. Nasim et al. / International Journal of Surgery 9 (2011) 456e459 459
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preference. Of these patients, 76% were ASA III/IV. Thus, it can be
concluded that PC is not only efﬁcacious as a temporizing proce-
dure before a deﬁnitive treatment, but is also a possible ‘deﬁnitive’
treatment option for high risk, elderly patients having cholecystitis.
In conclusion, percutaneous cholecystostomy has a role in the
deﬁnitive management of selected high risk group patients with
acute cholecystitis. Our data suggests that up to one-third of
patients with acute calculous cholecystitis and 50% of patients with
acalculous cholecystitis can be managed successfully with this
modality. It is convenient, has a relatively low and acceptable
complication rate and is rapidly effective. Interval laparoscopic
cholecystectomy can be safely performed. The high success rate and
the low procedure-related complications of percutaneous chol-
ecystostomy have encouraged and expanded its utilization. We feel
that this modality can be used as deﬁnitive management for
patients with acute calculous cholecystitis if the risk of surgery is
not acceptable to the health care provider or the patient, without
assuming the necessity of an interval cholecystectomy following
resolution of the acute episode. Indeed, planning for an elective
procedure in a high risk patient almost always triggers a series of
expensive and time consuming consultations and investigations
that not only burden health care systems, but cause undue stress
for patients and their care-givers. A prospective study is planned to
better capture patient characteristics and outcomes in this group of
patients and will assist in developing guidelines for care.
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